NR4A1 and neoplasm: The 70-gene signature emerged as a prognostic factor for LRR in a competing risk analysis which included clinical-pathological risk factors such as age, tumor size, grade, hormone receptor status, lymphovascular invasion, axillary lymph node involvement, surgical treatment, ET, and chemotherapy (80).